See also our related blogs for the Keller Laboratory and the Pediatric Preclinical Testing Initiative.
Showing posts with label Knight Cancer Institute. Show all posts
Showing posts with label Knight Cancer Institute. Show all posts

Thursday, May 10, 2012

(re-posted from the AYA Voice)

In a joint effort with our community partners, Familias en Accion and Oncology Youth Connection, the Adolescent and Young Adult Oncology Program will begin our Cancer Transitions sessions. The program aims to help young adult patients (aged 18-39 at time of session start) with cancer, who are transitioning from active treatment to survivorship. Participants need to have completed treatment in the last two years. Beginning Thursday, May 24, 2012, the six-week program will focus on a new area of survivorship each week, providing information on things like tips for healthy eating, how to keep exercise in a busy schedule, and how to take control of survivorship. We’ll also provide tools for working through the emotional and social hurdles faced during the transition period after treatment, as well as give AYAs a chance to connect with others and learn they are not alone. So if you are a survivor, or you know someone who could benefit from this FREE program, please email Mindy or call 503-494-0446 to get more information or to register. Space is limited.
Adolescents and young adults with cancer have different needs from other patients. The Knight Cancer Institute is proud to offer Oregon's only program designed exclusively for people ages 15-39. Our internationally-recognized, award-winning Adolescent and Young Adult Oncology Program is dedicated to ensuring all AYAs with cancer have access to services tailored to their specific needs.

Wednesday, May 2, 2012

Dr. Langenau gives Scott Michael Carter Memorial Lectureship

We are excited to welcome MGH cancer researcher, Dr. David Langenau, 4pm on Tuesday May 6 to present the second annual Scott Michael Carter Memorial Lectureship, “Self-renewal mechanisms in T-cell Leukemia and Rhabdomyosarcoma”.  The Knight Cancer Institute seminar series lecture will be held in the OHSU Main Hospital auditorium, room 8B60.  
  
For more information on the Scott Carter Foundation, and Scott's selfless legacy, click here.  
  
Live stream 4pm PST:  click here

Sunday, January 8, 2012

Knight Cancer Institute Seminar Series speaker, Dr. Robin Jones (Seattle)

We are pleased to have Dr. Robin Jones, Director of the Bob & Eileen Gilman Family Sarcoma Research Program of the Fred Hutchinson Cancer Research Center and the Seattle Cancer Care Alliance, with colleague physician-scientist Dr. Seth Pollack giving the their joint seminar, "Novel Therapeutic Strategies in Sarcoma" on Tuesday January 17 at 4pm in the OHSU Main Hospital 8th Floor Conference Room 8B60.  The public is welcome, and after the seminar a stream of the lecture will be available here.  

Monday, July 18, 2011

Pediatric Hematology-Oncology Fellowship at OHSU

The Pediatric Hematology Oncology Fellowship program at OHSU is an exciting one with not only an outstanding clinical training experience, but  superb research training as well.  More information about this ACGME-accredited can be seen here, including a video about the childhood cancer program at OHSU Doernbecher Children's Hospital.  You can also contact program director, Dr. Michael Recht, rechtm (at) ohsu.edu .   

Sunday, May 22, 2011

Upcoming Knight Seminar Speakers


OHSU Main Hospital 8th Floor Conference Room 8B60

4:00 p.m. Tuesday, June 14, 2011
James M. Ford, MD
Associate Professor of Medicine, Pediatrics & Genetics
Stanford University School of Medicine
Targeting DNA Repair for the Treatment & Prevention of Triple‐Negative Breast Cancer
hosted by Charles Lopez, MD, PhD, Cell & Developmental Biology ‐ OHSU
  
  
  
4:00 p.m. Tuesday, June 21, 2011
William Stratford May, Jr. , MD, PhD
Henry E. Innes Professor of Cancer Research
UF Shands Cancer Center, University of Florida
TNK1/KOS1: A Protein Tyrosine Kinase with a Tumor Suppressor Function
hosted by Jeffrey Tyner, PhD, Knight Cancer Institute